← back to search

Daniel C. Chung

Harvard University · US
Area of research
Oncology · Pathology and Forensic Medicine
Research interest
Research interests include Genetic factors in colorectal cancer, Colorectal Cancer Screening and Detection, Pancreatic and Hepatic Oncology Research, and Colorectal Cancer Treatments and Studies.
h-index
62
citations
20,780
works
342
NIH funding
primary concept
Medicine
email

Recent publications

Feasibility and acceptability of an electronic decision aid for genetic testing in ovarian and pancreatic cancer patients.
2026cited by 0position: contributordoi
Association of distinct microbial and metabolic signatures with microscopic colitis
Nature Communications 2025cited by 7position: middledoi
Germline <i>CDH1</i> Variants and Lifetime Cancer Risk
JAMA 2024cited by 52position: middledoi
The Pancreatic Cancer Early Detection (PRECEDE) Study is a Global Effort to Drive Early Detection: Baseline Imaging Findings in High-Risk Individuals
Journal of the National Comprehensive Cancer Network 2024cited by 21position: middledoi
Composition and Function of the Gut Microbiome in Microscopic Colitis
2024cited by 2position: contributordoi
Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer.
2024cited by 0position: contributordoi
Data from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
2024cited by 0position: contributordoi
Supplemental Figure 1 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
2024cited by 0position: contributordoi
Supplemental Table 2 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
2024cited by 0position: contributordoi
Supplemental Figure 4 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
2024cited by 0position: contributordoi
Supplemental Figure 1 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
2024cited by 0position: contributordoi
Data from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
2024cited by 0position: contributordoi
Supplemental Figure 5 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
2024cited by 0position: contributordoi
Supplemental Table 2 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
2024cited by 0position: contributordoi
Supplemental Figure 4 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
2024cited by 0position: contributordoi
Supplemental Figure 3 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
2024cited by 0position: contributordoi
Supplemental Figure 5 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
2024cited by 0position: contributordoi
Supplemental Figure 3 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
2024cited by 0position: contributordoi
Supplemental Figure 2 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
2024cited by 0position: contributordoi
Supplemental Figure 2 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
2024cited by 0position: contributordoi
Supplemental Table 1 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
2024cited by 0position: contributordoi
Supplemental Table 1 from Stool Protein Mass Spectrometry Identifies Biomarkers for Early Detection of Diffuse-type Gastric Cancer
2024cited by 0position: contributordoi
Association of distinct microbial signatures with premalignant colorectal adenomas
Cell Host & Microbe 2023cited by 43position: lastdoi
Racial, Ethnic, and Sex-based Disparities among High-risk Individuals Undergoing Pancreatic Cancer Surveillance
Cancer Prevention Research 2023cited by 20position: middledoi
WPOI-5: Accurately Identified at Intraoperative Consultation and Predictive of Occult Cervical Metastases
Head and Neck Pathology 2023cited by 9position: middledoi
A pooled electronic consultation program to improve access to genetics specialists.
2023cited by 3position: contributordoi
A Pooled Electronic Consultation Program to Improve Access to Genetics Specialists
2023cited by 2position: contributordoi
Surveillance Outcomes in Patients With a Family History of Colorectal Cancer in Both Parents.
2023cited by 0position: contributordoi
Large-scale sequencing identifies multiple genes and rare variants associated with Crohn’s disease susceptibility
Nature Genetics 2022cited by 182position: middledoi
Computer-Aided Detection Improves Adenomas per Colonoscopy for Screening and Surveillance Colonoscopy: A Randomized Trial
Gastroenterology 2022cited by 137position: middledoi

Grants

Interface of High Energy Theory and Cosmology
NSF0506002$30,0002005–2006PIRePORTER

Frequent collaborators

· 24 papers (2019–2026)Andrew T. Chan · Massachusetts General Hospital17 papers (2024–2024)Chi-Lee C. Ho · University of Pennsylvania17 papers (2024–2024)Samuel J. Klempner · Mass General Brigham17 papers (2024–2024)Jeeyun Lee · Severance Hospital17 papers (2024–2024)Jeremy Davis · Maine Farmland Trust17 papers (2024–2024) · 17 papers (2024–2024) · 17 papers (2024–2024)Yuen-Yi Tseng · Dana-Farber Cancer Institute17 papers (2024–2024)David A. Drew · Dana-Farber Cancer Institute17 papers (2024–2024)Sandra Ryeom · University of Pennsylvania17 papers (2024–2024)Guillaume Urtecho · Massachusetts Institute of Technology17 papers (2024–2024)Harris H. Wang · New York Proton Center17 papers (2024–2024)Hyoungjoo Lee · Sungkyunkwan University17 papers (2024–2024)Hyuk Lee · University of Pennsylvania17 papers (2024–2024)Alexander Caraballo · Harvard University17 papers (2024–2024)Naryan Rustgi · Columbia University17 papers (2024–2024) · 17 papers (2024–2024)Jin S. Cho · Columbia University Irving Medical Center17 papers (2024–2024)Carmen Rios · Dana-Farber Cancer Institute17 papers (2024–2024)